Recent Publications

Recent Publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013

2022

Dec 05, 2022
Nakadai, T., Yang, L., Kumegawa, K. and Maruyama, R.
Estrogen receptor α K303R mutation reorganizes its binding to forkhead box protein A1 regions and induces chromatin opening.
Molecular biology reports, in press (2022)
Nov 08, 2022
Haga, Y., Yamada, M., Fujii, R., Saichi, N., Yokokawa, T., Hama, T., Hayakawa, Y. and Ueda, K.
Fast and ultrasensitive glycoform analysis by supercritical fluid chromatography-tandem mass spectrometry.
Anal. Chem., in press (2022)
Oct 28, 2022
Huang, S., Haga, Y., Li, J., Zhang, J., Kweon, H. K., Seino, J., Hirayama, H., Fujita, M., Moremaen, K., Andrews, P., Suzuki, T. and Wang, Y.
Mitotic phosphorylation inhibits the Golgi mannosidase MAN1A1.
Cell Rep., in press (2022)
Aug 23, 2022
Minegishi, Y., Kiyotani, K., Nemoto, K., Inoue, Y., Haga, Y., Fujii, R., Saichi, N., Nagayama, S. and Ueda, K.
Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations.
Commun. Biol., in press (2022)
Aug 23, 2022
Ochiai, R., Hayashi, K., Yamamoto, H., Fujii, R., Saichi, N., Shinchi, H., Ishida, T., Honda, T., Shimizu, T., Matsutani, N., Seki, N., Kawamura, M. and Ueda, K.
Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment.
Cancer Sci., in press (2022)
Aug 16, 2022
Namikawa, K., Tanaka, N., Ota, Y., Takamatsu, M., Kosugi, M., Tokai, Y., Yoshimizu, S., Horiuchi, Y., Ishiyama, A., Yoshio, T., Hirasawa, T., Amino, S., Furuya, R., Gotoh, O., Kaneyasu, T., Nakayama, I., Imamura, Y., Noda, T., Fujisaki, J. and Mori, S.
Genomic features of Helicobacter pylori-naïve diffuse-type gastric cancer.
J. Pathol., in press (2022)
Aug 16, 2022
Sakashita, T., Yanagitani, N., Koike, S., Low, S. K., Takagi, S., Baba, S., Takeuchi, K., Nishio, M., Fujita, N. and Katayama, R.
Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.
Cancer Sci., in press (2022)
Jul 21, 2022
Fukuoka, M., Ichikawa, Y., Osako, T., Fujita, T., Baba, S., Takeuchi, K., Tsunoda, N., Ebata, T., Ueno, T., Ohno, S. and Saitoh, N.
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer.
Cancer Sci., in press (2022)
Jul 19, 2022
Igarashi, N., Miyata, K., Loo, T. M., Chiba, M., Hanyu, A., Nishio, M., Kawasaki, H., Zheng, H., Toyokuni, S., Kon, S., Moriyama, K., Fujita, Y. and Takahashi, A.
Hepatocyte growth factor derived from senescent cells attenuates cell competition-induced apical elimination of oncogenic cells.
Nat. Commun., in press (2022)
Jul 08, 2022
Kunimasa, K., Ikeda-Ishsikawa, C., Tani, Y., Tsukahara, S., Sakurai, J., Okamoto, Y., Koido, M., Dan, S. and Tomida, A.
Spautin-1 inhibits mitochondrial complex I and leads to suppression of the unfolded protein response and cell survival during glucose starvation.
Sci. Rep., 12, 11533 (2022)
Jun 21, 2022
Shimizu, Y., Maruyama, K., Suzuki, M., Kawachi, H., Low, S. K., Oh-Hara, T., Takeuch, K., Fujita, N., Nagayama, S. and Katayama, R.
Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma.
Cancer Lett., in press (2022)
Jun 20, 2022
Ebata, H., Loo, T. M. and Takahashi, A.
Telomere maintenance and the cGAS-STING pathway in cancer.
Cells, in press (2022)
Jun 20, 2022
Kumegawa, K., Takahashi, Y., Saeki, S., Yang, L., Nakadai, T., Osako, T., Mori, S., Noda, T., Ohno, S., Ueno, T. and Maruyama, R.
GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer.
NPJ Breast Cancer, 8, 70 (2022)
May 26, 2022
Ohta, K., Fushimi, T., Okamura, M., Akatsuka, A., Dan, S., Iwasaki, H., Yamashita, M. and Kojima, N.
Structure–antitumor activity relationship of hybrid acetogenins focusing on connecting groups between heterocycles and the linker moiety.
RSC Advances, 12, 15728-15739 (2022)
May 11, 2022
Moyret-Lalle, C., Prodhomme, M. K., Burlet, D., Kashiwagi, A., Petrilli, V., Puisieux, A., Seimiya, H. and Tissier, A.
Role of EMT in the DNA damage response, double-strand break repair pathway choice and its implications in cancer treatment.
Cancer Sci., in press (2022)
May 09, 2022
Tanaka, N., Mori, S., Kiyotani, K., Ota, Y., Gotoh, O., Kusumoto, S., Nakano, N., Suehiro, Y., Ito, A., Choi, I., Ohtsuka, E., Hidaka, M., Nosaka, K., Yoshimitsu, M., Imaizumi, Y., Iida, S., Utsunomiya, A., Noda, T., Nishikawa, H., Ueda, R. and Ishida, T.
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma.
Haematologica, in press (2022)
May 06, 2022
Adachi, J., Kakudo, A., Takada, Y., Isoyama, J., Ikemoto, N., Abe, Y., Narumi, R., Muraoka, S., Gunji, D., Hara, Y., Katayama, R. and Tomonaga, T.
Systematic identification of ALK substrates by integrated phosphoproteome and interactome analysis.
Life Sci. Alliance, 5, e202101202 (2022)
Apr 08, 2022
Matsumori, H., Watanabe, K., Tachiwana, H., Fujita, T., Ito, Y., Tokunaga, M., Sakata-Sogawa, K., Osakada, H., Haraguchi, T., Awazu, A., Ochiai, H., Sakata, Y., Ochiai, K., Toki, T., Ito, E., Goldberg, I. G., Tokunaga, K., Nakao, M. and Saitoh, N.
Ribosomal protein L5 facilitates rDNA-bundled condensate and nucleolar assembly.
Life science alliance, 5, e202101045 (2022)
Apr 06, 2022
Takemoto, A., Takagi, S., Ukaji, T., Gyobu, N., Kakino, M., Takami, M., Kobayashi, A., Lebel, M., Kawaguchi, T., Sugawara, M., Tsuji-Takayama, K., Ichihara, K., Funauchi, Y., Ae, K., Matsumoto, S., Sugiura, Y., Takeuchi, K., Noda, T., Katayama, R. and Fujita, N.
Targeting podoplanin for the treatment of osteosarcoma.
Clin. Cancer Res., in press (2022)
Mar 18, 2022
Shimizu, Y., Okada, K., Adachi, J., Abe, Y., Narumi, R., Uchibori, K., Yanagitani, N., Koike, S., Takagi, S., Nishio, M., Fujita, N. and Katayama, R.
GSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancer.
NPJ Precis. Oncol., in press (2022)
Mar 08, 2022
Osako, T., Matsuura, M., Yotsumoto, D., Takayama, S., Kaneko, K., Takahashi, M., Shimazu, K., Yoshidome, K., Kuraoka, K., Itakura, M., Tani, M., Ishikawa, T., Ohi, Y., Kinoshita, T., Sato, N., Tsujimoto, M., Nakamura, S., Tsuda, H., Noguchi, S. and Akiyama, F.
A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort study.
Cancer, in press (2022)
Mar 03, 2022
Tanimura, K., Yamada, T., Okada, K., Nakai, K., Horinaka, M., Katayama, Y., Morimoto, K., Ogura, Y., Takeda, T., Shiotsu, S., Ichikawa, K., Watanabe, S., Morimoto, Y., Iwasaku, M., Kaneko, Y., Uchino, J., Taniguchi, H., Yoneda, K., Matoba, S., Sakai, T., Uehara, H., Yano, S., Kusaba, T., Katayama, R. and Takayama, K.
HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.
NPJ Precis Oncol, 6, 5 (2022)
Feb 16, 2022
Miyata, K. and Takahashi, A.
Pericentromeric repetitive ncRNA regulates chromatin interaction and inflammatory gene expression.
Nucleus, 13, 74-78 (2022)
Feb 14, 2022
Yoshida, Y., Yuki, K., Dan, S., Yamazaki, K. and Noda, M.
Suppression of tumor metastasis by a RECK-activating small molecule.
Sci. Rep., 12, 2319 (2022)
Feb 14, 2022
Haga, Y. and Ueda, K.
Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques.
Glycoconj J, in press (2022)
Jan 04, 2022
Sagawa, R., Sakata, S., Gong, B., Seto, Y., Takemoto, A., Takagi, S., Ninomiya, H., Yanagitani, N., Nakao, M., Mun, M., Uchibori, K., Nishio, M., Miyazaki, Y., Shiraishi, Y., Ogawa, S., Kataoka, K., Fujita, N., Takeuchi, K. and Katayama, R.
Soluble PD-L1 through alternative polyadenylation works as a decoy in lung cancer immunotherapy.
JCI insight, in press (2021)

Return to Top of Page